TL;DR High OEE does not guarantee optimal operational performance. Bottlenecks often originate outside of equipment effectiveness. Real-time scheduling provides broader visibility into the value stream. Simulation helps identify the root causes behind performance...
TL;DR Many life sciences manufacturers still rely on spreadsheet-based scheduling. Manual scheduling is prone to errors, delays, and limited visibility. DeltaV Real Time scheduling software dynamically adapts to plant conditions. Integrated scheduling improves...
TL;DR Sustainability initiatives require efficient use of limited resources. Automation enables measurable improvements in energy use and emissions. Monitoring WAGES systems is key to identifying waste. Modern control and reliability tools reduce inefficiencies and...
Life sciences manufacturers face increasing pressure to ensure regulatory compliance, real-time release, and validated process control as they scale production. When measurement confidence is low, teams add manual checks, increase calibration frequency, and accept downtime that delays the next batch.
Why this matters now The last few decades of biopharmaceutical research have seen an explosion in new therapies, many of which treat illnesses once thought impossible to manage. As innovation continues at an unprecedented pace, life sciences manufacturers are under...
More than 10,000 rare diseases affect over 30 million people in the United States alone, and 95 percent of those diseases have no approved treatment. With more than 1,000 active clinical programs working to change that, the pressure on biopharmaceutical manufacturers to accelerate the pipeline without compromising quality or compliance has never been greater.
As explored in his recent interview in Pharmaceutical Processing World, Emerson’s Bruce Greenwald—drawing on decades of experience—explains that life sciences manufacturers are moving beyond isolated systems toward connected plants to achieve operational excellence...
In Life Sciences manufacturing, flow measurement is never just about measurement. It’s about protecting product quality, maintaining validation, and ensuring every batch meets exacting regulatory expectations without slowing down operations. That’s exactly why we...
Life sciences may be the ideal industry for the implementation of AI technologies. After all, bringing a treatment all the way through the drug development process is an extremely complicated undertaking, with tremendous amounts of data and a wide array of...
Across industries—from chemical and energy to life sciences—operators are being asked to do more with less. Processes must run reliably, systems must integrate smoothly, and regulatory expectations continue to rise. At the same time, traditional approaches to flow...
AI is changing drug discovery faster than most people expected. Commercial manufacturing is next. The organizations best positioned for that shift are the ones preparing now, not because they’re behind, but because the window to prepare thoughtfully is exactly when...
In the wake of the COVID-19 pandemic and the associated development of a vaccine in record time, the biopharmaceutical industry has seen significant change. Today, we know that faster development is possible, though it is still challenging. That has increased the...
We invite you to follow us on Facebook, LinkedIn, Twitter and YouTube to stay up to date on the latest news, events and innovations that will help you face and solve your toughest challenges.
Just post a link to the entry and send us a quick note so we can share your work. Thank you very much.
Our Global Community
Emerson Exchange 365
This blog features expert perspectives from Emerson's automation professionals on industry trends, technologies, and best practices. The information shared here is intended to inform and educate our global community of users and partners.